A Canadian clinical trial led by researchers at the University of Calgary’s Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.
Three in five teenagers surveyed by the British Skin Foundation reported ‘a fall in self-confidence’ as the biggest impact that acne has on their lives. From my experience as a dermatologist I find that those with acne can often feel unsupported, socially isolated and become withdrawn.
Researchers, led by Dr Huiying Li, an associate professor of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, used over-the-counter pore cleansing strips to obtain skin follicle samples from 72 individuals: 38 with acne and 34 who didn’t have the disease.
Growing up can be hard for any teenager without the added stress of acne. Sadly acne affects around 80% of adolescents aged 13-18 years at some point.
Acne develops due to an interplay between genetic factors (so people often have a family history) and hormonal factors that can increase the size and activity of the sebaceous or oil gland.
The mesoporous material Upsalite is shown to inhibit growth of bacteria associated with acne and hospital acquired infections.
The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.
From drug of choice to poison, diuretic and skin nemesis, coffee often gets a bad rap. But for those of us in Australia who drink 2.1 billion cups bought from cafes or vendors each year, while it may pick us up and disrupt our sleep, that first sip of …
Novan, Inc. today announced that the first patient has been dosed in its Phase 3 program to evaluate the efficacy and safety of its topical nitric oxide product candidate SB204 Gel in the treatment of acne vulgaris (“acne”). The Company is running two identically designed Phase 3 pivotal trials in parallel and expects to report […]